当前位置:首页 - 行情中心 - 成大生物(688739) - 财务分析 - 现金流量表

成大生物

(688739)

  

流通市值:48.90亿  总市值:107.86亿
流通股本:1.89亿   总股本:4.16亿

现金流量表

报告期2024-09-302024-06-302024-03-312023-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金1,213,054,527.77785,690,637.01353,763,410.471,818,432,008.19
收到的税费返还722,037.1722,037.1381,952.04757,937.59
收到其他与经营活动有关的现金42,165,914.4127,951,795.0915,654,489.8777,201,443.52
经营活动现金流入的平衡项目0000
经营活动现金流入小计1,255,942,479.28814,364,469.2369,799,852.381,896,391,389.3
购买商品、接受劳务支付的现金232,953,361.46162,788,582.0180,887,065.04248,868,748.92
支付给职工以及为职工支付的现金276,959,344.71200,102,425.55134,655,563.58333,082,881.29
支付的各项税费135,750,830.4985,275,101.1432,036,809.66182,844,938.36
支付其他与经营活动有关的现金319,100,880.76210,984,097.3288,967,728.37454,586,883.68
经营活动现金流出的平衡项目0000
经营活动现金流出小计964,764,417.42659,150,206.02336,547,166.651,219,383,452.25
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额291,178,061.86155,214,263.1833,252,685.73677,007,937.05
二、投资活动产生的现金流量:
收回投资收到的现金3,174,245,266.251,533,874,646.25672,073,747.095,453,802,241.85
取得投资收益收到的现金20,855,345.4610,132,687.963,720,475.6133,275,063.94
处置固定资产、无形资产和其他长期资产收回的现金净额10,887,081.5610,895,111.656,058,00019,611.65
投资活动现金流入的平衡项目0000
投资活动现金流入小计3,205,987,693.271,554,902,445.86681,852,222.75,487,096,917.44
购建固定资产、无形资产和其他长期资产支付的现金260,020,189.93168,860,297.7894,645,469.52551,989,885.2
投资支付的现金3,138,370,6201,579,000,000560,000,0006,337,000,000
支付其他与投资活动有关的现金44,707.1232,473.0921,557.49390,323.75
投资活动现金流出的平衡项目0000
投资活动现金流出小计3,398,435,517.051,747,892,770.87654,667,027.016,889,380,208.95
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-192,447,823.78-192,990,325.0127,185,195.69-1,402,283,291.51
三、筹资活动产生的现金流量:
分配股利、利润或偿付利息支付的现金329,362,680.8329,362,680.8-416,321,900
支付其他与筹资活动有关的现金53,427,214.4447,753,674.5717,577,468.25106,368,889.96
筹资活动现金流出平衡项目0000
筹资活动现金流出小计382,789,895.24377,116,355.3717,577,468.25522,690,789.96
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-382,789,895.24-377,116,355.37-17,577,468.25-522,690,789.96
四、汇率变动对现金及现金等价物的影响370,851.59598,172.7441,736.172,290,411.04
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-283,688,805.57-414,294,244.4642,902,149.34-1,245,675,733.38
加:期初现金及现金等价物余额4,544,605,341.534,544,605,341.534,544,605,341.535,790,281,074.91
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额4,260,916,535.964,130,311,097.074,587,507,490.874,544,605,341.53
补充资料:
净利润-220,213,309.97-465,923,566.68
资产减值准备-20,060,706.72-109,805,229.7
固定资产和投资性房地产折旧-78,253,001.25-114,224,928.66
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-78,253,001.25-114,224,928.66
无形资产摊销-3,242,897.53-6,010,767.82
长期待摊费用摊销-1,800,445.68-3,705,193.75
处置固定资产、无形资产和其他长期资产的损失--90,854.59--2,482,317.43
固定资产报废损失-1,530,491.51-871,276.13
公允价值变动损失-10,938,482.4--8,102,948.8
财务费用--155,232.73--1,296,997.21
投资损失--8,228,475.14--25,022,730.62
递延所得税--4,300,182.63--7,214,455.19
其中:递延所得税资产减少-5,144,460.29--10,935,150.24
递延所得税负债增加--9,444,642.92-3,720,695.05
存货的减少--35,809,773.25-419,833.16
经营性应收项目的减少--123,588,447.11-13,823,094.37
经营性应付项目的增加--20,834,746.16--11,838,363.55
其他-26,273.09-62,011.75
现金的期末余额-4,130,311,097.07-4,544,605,341.53
减:现金的期初余额-4,544,605,341.53-5,790,281,074.91
公告日期2024-10-302024-08-302024-04-302024-04-23
审计意见(境内)标准无保留意见
TOP↑